| |
|
|
|
Viking Therapeutics Inc.  
|
|
6.535 -0.165 (-0.02%) |
10-18 16:00 |
|
Open: |
6.66 |
Pre close: |
6.7 |
Target:
|
8.18
|
|
High: |
6.795 |
Low: |
6.46 |
Resistance:
|
7.00
7.53
|
|
Volume: |
745,578 |
Market Cap: |
472M |
Support:
|
6.15
5.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.57
 |
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
6.70  |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
7.44 |
Stochastic Oscillator |
%K(14,3):
|
42.99 |
|
MA(250): |
8.59 |
%D(3): |
40.24 |
|
Average Volume(K) |
3-Month: |
131275
|
52-Week |
High:
|
15.69 |
|
10-Days: |
92935 |
Low: |
6.15 |
|
RSI |
RSI(14):
|
43.05 |
Change(%): |
-52.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.350 |
Return on Equity (ttm) |
-11.4 |
Shares Out. (M) |
72.21 |
|
EPS Est. Current Year |
-0.830 |
Return on Assets (ttm) |
-8.8 |
Shares Float (M) |
57.44 |
|
EPS Est. Next Year |
-0.800 |
PEG Ratio |
-0.33 |
% Held by Insiders |
11.03 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
68.50 |
|
Forward EPS |
-0.490 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
21100 |
|
Book Value (p.s.) |
3.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-18.67 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.64 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.79 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-13.24 |
P/CF |
-26.53 |
|
|
|
|
|
|
